| James L Baldwin, MD | |
|
24 Frank Lloyd Wright Dr, Suite H-2100, Ann Arbor, MI 48105-9484 | |
| (734) 647-5940 | |
| Not Available |
| Full Name | James L Baldwin |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 35 Years |
| Location | 24 Frank Lloyd Wright Dr, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508955428 | NPI | - | NPPES |
| 3085807 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 4301064624 (Michigan) | Primary |
| 207R00000X | Internal Medicine | 4301064624 (Michigan) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Michigan Health System | Ann arbor, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regents Of The University Of Michigan | 3779496856 | 2953 |
News Archive
Cincinnati Cancer Center (CCC) and UC Cancer Institute researchers have found that a vaccine, targeting tumors that produce a certain protein and receptor responsible for communication between cells and the body's immune system, could initiate the immune response to fight cancer.
A strain of the bacteria Streptococcus pneumoniae, which can cause ear infections in children, has been detected that is resistant to all FDA-approved antibiotics for treatment of ear infections and is not covered by the pneumococcal 7-valent conjugate vaccine, according to a study in the October 17 issue of JAMA.
Arteriocyte, a leading clinical stage biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts that develops proprietary stem cell and tissue engineering based therapies, announced today approval from the Food and Drug Administration to initiate a Phase I clinical trial using its Magellan MAR01 technology in the treatment of Critical Limb Ischemia.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today it will present several poster presentations at the 61st Annual Meeting of the American Association for the Study of Liver Diseases being held in Boston, Mass from October 29 - November 2, 2010.
› Verified 6 days ago
| Entity Name | Regents Of The University Of Michigan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700816881 PECOS PAC ID: 3779496856 Enrollment ID: O20031113000672 |
News Archive
Cincinnati Cancer Center (CCC) and UC Cancer Institute researchers have found that a vaccine, targeting tumors that produce a certain protein and receptor responsible for communication between cells and the body's immune system, could initiate the immune response to fight cancer.
A strain of the bacteria Streptococcus pneumoniae, which can cause ear infections in children, has been detected that is resistant to all FDA-approved antibiotics for treatment of ear infections and is not covered by the pneumococcal 7-valent conjugate vaccine, according to a study in the October 17 issue of JAMA.
Arteriocyte, a leading clinical stage biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts that develops proprietary stem cell and tissue engineering based therapies, announced today approval from the Food and Drug Administration to initiate a Phase I clinical trial using its Magellan MAR01 technology in the treatment of Critical Limb Ischemia.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today it will present several poster presentations at the 61st Annual Meeting of the American Association for the Study of Liver Diseases being held in Boston, Mass from October 29 - November 2, 2010.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James L Baldwin, MD 3621 S State St, 700 Kms Place, Ann Arbor, MI 48108 Ph: (734) 936-2047 | James L Baldwin, MD 24 Frank Lloyd Wright Dr, Suite H-2100, Ann Arbor, MI 48105-9484 Ph: (734) 647-5940 |
News Archive
Cincinnati Cancer Center (CCC) and UC Cancer Institute researchers have found that a vaccine, targeting tumors that produce a certain protein and receptor responsible for communication between cells and the body's immune system, could initiate the immune response to fight cancer.
A strain of the bacteria Streptococcus pneumoniae, which can cause ear infections in children, has been detected that is resistant to all FDA-approved antibiotics for treatment of ear infections and is not covered by the pneumococcal 7-valent conjugate vaccine, according to a study in the October 17 issue of JAMA.
Arteriocyte, a leading clinical stage biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts that develops proprietary stem cell and tissue engineering based therapies, announced today approval from the Food and Drug Administration to initiate a Phase I clinical trial using its Magellan MAR01 technology in the treatment of Critical Limb Ischemia.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today it will present several poster presentations at the 61st Annual Meeting of the American Association for the Study of Liver Diseases being held in Boston, Mass from October 29 - November 2, 2010.
› Verified 6 days ago
Aimee Leyton Speck, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 24 Frank Lloyd Wright Dr, Suite H-2100, Ann Arbor, MI 48105 Phone: 734-647-5940 | |
Mohammed R Rafeeq, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 24 Frank Lloyd Wright Dr, Ann Arbor, MI 48105 Phone: 734-647-5940 | |
Georgiana M Sanders, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 24 Frank Lloyd Wright Dr, Suite H-2100, Ann Arbor, MI 48105 Phone: 734-647-5940 | |
Ian Frederick Slack, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 24 Frank Lloyd Wright Dr, Ann Arbor, MI 48105 Phone: 734-647-5940 | |
Cynthia L Cookingham, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1500 East Medical Center Dr, 2nd Floor University Hospital Recp Pathology, Ann Arbor, MI 48109 Phone: 800-862-7284 | |
Sherry Zhou, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, 3116 Taubman Center, Spc 5368, Ann Arbor, MI 48109 Phone: 734-936-5582 |